Ledger.Open graph →
SEC Form D · Amendment · filed October 30, 2018

Acurx Pharmaceuticals, LLC

Offering
$7.0M
Sold
$3.8M
Exemption
Rule 506(b)
Industry
Biotechnology
Location
WHITE PLAINS, NY
Type
—

Rule 506(b): private placement to accredited investors, no public advertising.

People & firms on this filing (9)

Robert J. Deluccia · White Plains, NYDirectorRobert G. Shawah · White Plains, NYExecDavid P. Luci · White Plains, NYDirectorRon Storn · San Francisco, CADirectorJoanna Riley · San Francisco, CAExecUllas Naik · San Francisco, CADirectorThomas Lazay · Boston, MADirectorFiras Raouf · Boston, MAExecJeffrey C. Seller · NEW YORK, NYDirector

Public SEC Form D (Reg D) filing. · View issuer on SEC EDGAR ↗